Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus.

Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus.
复制标题

棕色和米色脂肪组织:肥胖和 2 型糖尿病的新型治疗策略

DOI:
10.1080/21623945.2020.1870060
复制
发表时间:
2021-12
期刊:
影响因子:
3.3
通讯作者:
Zhao B
Zhao B
中科院分区:
生物学4区
文献类型:
--
作者:
Cheng L;Wang J;Dai H;Duan Y;An Y;Shi L;Lv Y;Li H;Wang C;Ma Q;Li Y;Li P;Du H;Zhao B

文献摘要

参考文献

被引文献

相似文献

哺乳动物的脂肪组织可分为两种主要类型,即白色脂肪组织(WAT)和棕色脂肪组织(BAT)。按照经典观点,白色脂肪组织的主要功能是以甘油三酯的形式储存多余能量,而棕色脂肪组织是一种产热组织,在维持核心体温方面起着关键作用。白色脂肪细胞具有高度可塑性,在运动、寒冷暴露及其他因素刺激下可转分化为米色脂肪细胞,米色脂肪细胞在形态和功能特性上与棕色脂肪细胞有许多相似之处。这种现象也被称为“白色脂肪棕色化”。除了转分化,米色脂肪细胞也可由组织驻留祖细胞从头分化而来。激活棕色脂肪组织以及诱导白色脂肪棕色化能够加速糖脂摄取并降低胰岛素分泌需求,这可能是改善肥胖和2型糖尿病(T2DM)患者糖脂代谢及胰岛素抵抗的一种新策略。本综述主要探讨棕色和米色脂肪组织在肥胖和T2DM治疗中的意义,并重点关注棕色化诱导剂对肥胖和T2DM的作用,为肥胖和T2DM的防治提供全新的理论参考。
ABSTRACT Mammalian adipose tissue can be divided into two major types, namely, white adipose tissue (WAT) and brown adipose tissue (BAT). According to classical view, the main function of WAT is to store excess energy in the form of triglycerides, while BAT is a thermogenic tissue that acts a pivotal part in maintaining the core body temperature. White adipocytes display high plasticity and can transdifferentiate into beige adipocytes which have many similar morphological and functional properties with brown adipocytes under the stimulations of exercise, cold exposure and other factors. This phenomenon is also known as ‘browning of WAT’. In addition to transdifferentiation, beige adipocytes can also come from de novo differentiation from tissue-resident progenitors. Activating BAT and inducing browning of WAT can accelerate the intake of glycolipids and reduce the insulin secretion requirement, which may be a new strategy to improve glycolipids metabolism and insulin resistance of obese and type 2 diabetes mellitus (T2DM) patients. This review mainly discusses the significance of brown and beige adipose tissues in the treatment of obesity and T2DM, and focuses on the effect of the browning agent on obesity and T2DM, which provides a brand-new theoretical reference for the prevention and treatment of obesity and T2DM. Graphical Abstract
DOI: 10.1016/j.numecd.2012.01.013
发表时间: 2013-06-01
影响因子: 3.9
作者:
De Matteis, R.;Lucertini, F.;Cuppini, R.
通讯作者: Cuppini, R.
DOI: 10.3389/fendo.2011.00102
发表时间: 2011
影响因子: 5.2
作者:
Collins S
通讯作者: Collins S
DOI: 10.1097/sla.0000000000002465
发表时间: 2019-03
期刊: Annals of surgery
影响因子: 9
作者:
Abdullahi A;Auger C;Stanojcic M;Patsouris D;Parousis A;Epelman S;Jeschke MG
通讯作者: Jeschke MG
DOI: 10.1016/j.bbalip.2009.04.002
发表时间: 2009-06
影响因子: 4.8
作者:
Bickel, Perry E.;Tansey, John T.;Welte, Michael A.
通讯作者: Welte, Michael A.
DOI: 10.1038/s41598-018-25866-y
发表时间: 2018-05-21
期刊: Scientific reports
影响因子: 4.6
作者:
Blumenfeld NR;Kang HJ;Fenzl A;Song Z;Chung JJ;Singh R;Johnson R;Karakecili A;Feranil JB;Rossen NS;Zhang V;Jaggi S;McCarty B;Bessler S;Schwartz GJ;Grant R;Korner J;Kiefer FW;Gillette BM;Sia SK
通讯作者: Sia SK